Press release
High-Level Usage Of AI In Healthcare To Drive The Ineffective Esophageal Motility Treatment Market At A CAGR Of 6%
The Ineffective Esophageal Motility Treatment Market is slated to grow at a gracious rate of 6% by the year 2030. With value-oriented approach being the need of the hour, the healthcare vertical is likely to go the technologically advanced way in the next 10 years. With Big Data, AI comprising these advancements, the healthcare vertical is bound to create greater strides going forward.Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
How About Looking Through The Sample Of Ineffective Esophageal Motility Treatment Market Report? https://www.persistencemarketresearch.com/samples/31550
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such as intake of asthma medications and increasing geriatric population, are also responsible for driving the ineffective esophageal motility treatment market.
According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020-2030).
Companies covered in Ineffective Esophageal Motility Treatment Market Report
Johnson & Johnson
Mylan Pharmaceutical
MediGus Ltd.
Torax Medical
Medtronic plc.
AstraZeneca plc.
Teva Pharmaceutical Industries Ltd.
Takeda Pharmaceutical Company Limited
GlaxoSmithKline plc.
Bayer AG
Pfizer Inc.
Bausch Health Companies Inc.
LABORIE
Mederi Therapeutics, Inc.
Becton, Dickinson and Company (C. R. Bard, Inc.)
EndoGastric Solutions, Inc
Olympus
Pentax
How About Step-By-Step Insights To Ineffective Esophageal Motility Treatment Market? Look Through The "Methodology" Employed! https://www.persistencemarketresearch.com/methodology/31550
Key Takeaways from Ineffective Esophageal Motility Treatment Market Study
Significant advantages of ineffective esophageal motility treatment; improving reimbursement scenario for surgical treatment devices; increasing awareness regarding gastric reflux disease; and large patient pool for GERD, dysphagia, achalasia, and burning chest pain are key factors propelling the growth of ineffective esophageal motility treatment market in developing regions.
North America is a prominent region the global ineffective esophageal motility treatment market, while East Asia is expected to offer lucrative growth opportunities, owing to the large population base and higher incidence of GERD and dysphagia.
Higher OTC antacid consumption is poised to drive the growth of the market.
Radiofrequency ablation systems with high level precision and procedural advantages over myotomy are expected to generate significant revenue in the long term.
Increasing adoption of ineffective esophageal motility treatment drugs for quick recovery as compared to device-based treatment marks higher revenue potential.
Raw material procurement issues, drug shortages, and reduced patient visits amidst the COVID-19 pandemic will adversely affect the growth of the ineffective esophageal motility treatment market in the near term.
"Procedural accuracy achieved by treatment devices and affordability of drug-based treatment are anticipated to drive the ineffective esophageal motility treatment market. Additionally, the large patient pool will bring in steady revenue opportunities," says a PMR analyst.
Want To Keep A Tab On The Latest Findings In The Ineffective Esophageal Motility Treatment Market? Purchase Our Ineffective Esophageal Motility Treatment Market Report Now! https://www.persistencemarketresearch.com/checkout/31550
New Product Launches by Key Players to Strengthen Market Presence
Key manufacturers in the ineffective esophageal motility treatment market are mainly focusing on research & development and introduction new & advanced treatment products. For example, LINX is the new and advanced version of the LINX reflux management device that is used for the transoral incision-less fundoplication process, which is one of the important procedures for the treatment of gastroesophageal reflux disease.
The innovation of new & advanced products is a factor boosting the ineffective esophageal motility treatment market. In addition, Olympus Corporation has launched advanced versions of esophagoscopes, which have improved the treatment curve of gastroesophageal reflux disease. Manufacturers are focusing on extended indication list and higher reimbursement to draw demand and increase profitability.
Alternatively, a key factor affecting the ineffective esophageal motility treatment market is the entry of generic drug manufacturers. Market leaders are constantly working on strengthening their strategies to gain market share.
What else is in the report?
Persistence Market Research offers a unique perspective and actionable insights on the ineffective esophageal motility treatment market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030, on the basis of product (drugs and devices), indication (GERD, dysphagia, achalasia, and burning chest pain), and end user (institutional sales and retail sales), across seven key regions.
Pulmonary Fibrosis Treatment Market: https://www.persistencemarketresearch.com/market-research/pulmonary-fibrosis-treatment-market.asp
Cutaneous And Systemic Leishmaniasis Market: https://www.persistencemarketresearch.com/market-research/cutaneous-and-systemic-leishmaniasis-market.asp
Contact Us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us:
Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release High-Level Usage Of AI In Healthcare To Drive The Ineffective Esophageal Motility Treatment Market At A CAGR Of 6% here
News-ID: 2628869 • Views: …
More Releases from Persistence Market Research

Fruit Ingredients Market to Reach US$ 111.3 Bn by 2032, Driven by Rising Health …
Overview of the Global Fruit Ingredients Market
The global fruit ingredients market is witnessing significant growth, driven by rising consumer demand for natural, clean-label, and nutrient-rich food products. In 2025, the market is likely to be valued at US$ 75.0 billion and is expected to reach US$ 111.3 billion by 2032, registering a robust CAGR of 5.8% during the forecast period. Fruit ingredients, which include fruit concentrates, purees, powders, and extracts,…

Vegan Dessert Market to Reach US$ 11.9 Bn by 2032, Driven by Rising Health & Pla …
Overview of the Market
The global vegan dessert market is poised for significant expansion, with an estimated valuation of US$ 5.2 billion in 2025, projected to reach US$ 11.9 billion by 2032. This robust growth reflects a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2025 to 2032. Increasing consumer awareness about health, environmental sustainability, and ethical food consumption is driving the widespread adoption of vegan dessert…

Instant Beverage Premix Market to Reach US$148.3 Bn by 2032 Driven by Convenienc …
Overview of the Global Instant Beverage Premix Market
The global instant beverage premix market has witnessed remarkable growth over the past decade, driven by evolving consumer lifestyles and increasing demand for convenient, ready-to-consume beverages. Instant beverage premixes, encompassing products such as instant coffee, tea, flavored drinks, protein powders, and nutritional supplements, cater to busy consumers seeking quick preparation without compromising on taste or nutritional value. These premixes have gained popularity across…

Dermacosmetics Market to Reach US$ 87.3 Bn by 2032 at 7.4% CAGR: Persistence Mar …
The global dermacosmetics market, estimated at US$ 53 billion in 2025, is forecasted to witness a steady upward trajectory, expanding at a Compound Annual Growth Rate (CAGR) of 7.4% to reach US$ 87.3 billion by 2032. This surge is driven by a confluence of factors ranging from increasing consumer awareness and the rising incidence of skin conditions to a growing preference for advanced, dermatologist-backed skincare solutions. Dermacosmetics, a category that…
More Releases for Ineffective
Terischwartz Associates Exposes the True Cost of Ineffective Meetings in Today's …
Image: https://www.abnewswire.com/upload/2025/07/3cd3e20ec6c36670720e5834999ed2ab.jpg
Executives across the country sit in boardrooms and virtual rooms alike, facing a steady stream of meetings that move agendas sideways, not forward. At the center of this epidemic lies a rarely acknowledged truth: most meetings lack a clear purpose, structure, or outcome. Despite their ubiquity, they remain one of the greatest hidden inefficiencies in modern business.
Evan Unger [https://www.terischwartzassociates.com/our-team/evan-unger/], managing partner at a national leadership consulting firm, studies this…
Ineffective Esophageal Motility Treatment Market is Predicted to Reach at a CAGR …
The ineffective esophageal motility treatment market is forecasted to reach a valuation of $4,488.8 million in 2024, and is expected to grow at a CAGR of 6.1% from 2024 to 2034, reaching approximately $8,080.7 million by 2034.
Key trends influencing this global market include advancements in diagnostic technologies, a shift towards personalized medicine, and innovations in treatment approaches. These factors are driving substantial advancements in the management of ineffective esophageal motility…
Steep learning curve and ineffective customer support keep AccountEdge second to …
Brandon, MB--May 25, 2023: AccountEdge helps small businesses establish inventory, billing, managing contacts, creating and tracking sales and purchases. It's compatible with both Mac and Windows operating systems. An on-premise and accounting management solution, it gives users the freedom to create an eCommerce platform where they can sell items online using Shopify, download orders directly to the account and synchronize the inventory items for selling. The banking tool gives…
Ineffective Esophageal Motility Treatment Market 2022 Global Market Analysis and …
Ineffective esophageal motility treatment leads to a reduction in muscle damage and improved outcomes, improving quality of life and resulting in long-term benefits. Device-based treatment and IEMT drugs have already had a substantial impact on how symptoms of GERD and achalasia are treated.
The first and the most important factor driving the growth of the ineffective esophageal motility treatment market is the increasing prevalence of gastroesophageal reflux disease. Other factors, such…
The Ineffective Esophageal Motility Treatment Market to keep pace with the lates …
The Ineffective Esophageal Motility Treatment Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients’ live – be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality.
Ineffective esophageal…
The Ineffective Esophageal Motility Treatment Market to Adopt Digitization
The Ineffective Esophageal Motility Treatment Market is there to witness remarkable growth in the forecast period. The existing scenario implies the consumerization of healthcare. In other words, technology is relieving the hospital staff from providing an appropriate level of the care needed, that too, in a better way. Data-driven diagnosis has seen the light of the day in wake of habits and requirements of smartphone-oriented patients. This would be the…